Back to search
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
Depressive Disorder, Major
Clinicaltrials.gov:
Other:
#89495120MDD2001
Trials at a glance
Status
Enrolling
Condition
Depressive Disorder, Major
Trial type
Interventional
Trial phase
Phase 2
Investigational
product
product
JNJ-89495120
Placebo
Age
18 to 64 years old
Biological sex
All
Placebo?
Yes
Trial start date
December 26, 2024
Trial end date
June 26, 2026
CT.gov ID
#NCT06785012
Share the trial ID with your doctor to see if trial participation is right for you. Participation depends on an independent medical assessment.
Countries:
- United States
Loading...
Enrolling
Orange, California, United States, 92866
Enrolling
Snellville, Georgia, United States, 30078
Enrolling
Clinton, Utah, United States, 84015
Enrolling
Redlands, California, United States, 92374
Enrolling
Bellflower, California, United States, 90706
Enrolling
Everett, Washington, United States, 98201
Enrolling
Indianapolis, Indiana, United States, 46202
Enrolling
Temecula, California, United States, 92591
Enrolling
Brooklyn, New York, United States, 11229
Enrolling
Tampa, Florida, United States, 33629
Enrolling
Maitland, Florida, United States, 32751
Enrolling
San Jose, California, United States, 95124
Enrolling
Columbus, Ohio, United States, 43210
Enrolling
Oklahoma City, Oklahoma, United States, 73116
Enrolling
Cincinnati, Ohio, United States, 45215
Enrolling
Miami, Florida, United States, 33126
Enrolling
McKinney, Texas, United States, 75071
Enrolling
Walnut Creek, California, United States, 94596
Enrolling
Atlanta, Georgia, United States, 30328
Enrolling
Santa Ana, California, United States, 92705
Enrolling
Hollywood, Florida, United States, 33021
Enrolling
Huntsville, Alabama, United States, 35801
Enrolling
Tucson, Arizona, United States, 85724
Enrolling
Chicago, Illinois, United States, 60637
Enrolling
Cincinnati, Ohio, United States, 45219
Enrolling
Worcester, Massachusetts, United States, 01655
Enrolling
Philadelphia, Pennsylvania, United States, 19104
Enrolling
Newport Beach, California, United States, 92660
Enrolling
Encino, California, United States, 91316
Enrolling
Miami, Florida, United States, 33135
Enrolling
Decatur, Georgia, United States, 30030
Completed
Homestead, Florida, United States, 33030
Completed
San Diego, California, United States, 92103
Completed
Pembroke Pines, Florida, United States, 33024
Completed
Gaithersburg, Maryland, United States, 20877
Completed
Chandler, Arizona, United States, 85224
Completed
North Charleston, South Carolina, United States, 29405
Completed
New Orleans, Louisiana, United States, 70115
Completed
Fort Myers, Florida, United States, 33912
Completed
Phoenix, Arizona, United States, 85012
Completed
Denver, Colorado, United States, 80209
Completed
Garden Grove, California, United States, 92844
Completed
Tucson, Arizona, United States, 85704
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Individual sites
Access detailed information on the trial:
Clinical trials information
© Johnson & Johnson and its affiliates 2026
